High-risk people don’t respond the same as others to PSAs
What if you could look into the brains of potential drug abusers and see what messages would be most likely to persuade them to “just say no?”
That’s the ultimate goal of researchers whose new study scanned the brains of people while they watched anti-drug public service announcements (PSAs).
The results provided new insights into how people at risk of drug use process anti-drug messages – and which messages they find most persuasive, said Richard Huskey, co-author of the study and assistant professor of communication at The Ohio State University.
“It is very difficult to ask potential drug users which anti-drug PSAs work best. They are generally very defensive and are apt to say that none of the messages is convincing,” Huskey said.
“Even though they often say that none of the anti-drug messages are effective, their brains tell a different story.”
Huskey conducted the study with J. Michael Mangus and René Weber, colleagues from the University of California, Santa Barbara, where he received his doctoral degree, and Benjamin Turner of Nanyang Technological University in Singapore.
The study appears in the December 2017 issue of the journal Social Cognitive and Affective Neuroscience.
For the study, 28 students at UCSB watched 32 real 30-second anti-drug PSAs while in an fMRI scanner. Half were at high risk of drug use and half were at low risk. Drug use risk was assessed with a validated self-report measure that the students had completed earlier.
Later, the participants rated each PSA on how strong its arguments against drug use were and on “perceived message sensation value” – how exciting the video was and how much it aroused the emotions and senses.
In analyzing the fMRI scans, the researchers looked specifically at connectivity patterns between different parts of the brain while the anti-drug messages played.
The researchers then took the results from these 28 fMRI participants and used them to predict how two large samples of people who weren’t scanned, but who did watch the same 32 PSAs, would rate the effectiveness of the messages. One group was 599 college students and the other was a nationally representative sample of 601 adolescents in the United States. These larger groups also included people who were at high risk for drug use and low risk.
Results showed that the self-report data alone from the high-risk fMRI participants couldn’t accurately predict if the larger groups of high-risk participants would say that any individual PSA was effective.
That’s not surprising, Huskey said, since drug users often either misidentify which messages are most effective or say that all the messages were equally ineffective.
But when the researchers combined the self-report data from the high-risk fMRI participants with their brain scan data, they could do a much better job at predicting which PSAs the larger groups of at-risk participants would find persuasive.
Specifically, they found that fMRI-measured connectivity between two parts of the brain – the middle frontal gyrus and the superior parietal lobe – significantly improved the accuracy in predicting which PSAs were most effective with this at-risk group.
But the fMRI scans among low-risk subjects didn’t help improve predictions of which videos participants would find most effective.
“That’s because low-risk subjects are accurately telling us which messages are most effective with them,” Huskey said.
“We don’t need fancy technology to figure out which messages work best for people who are at low risk – we can just ask them.”
This study alone can’t say exactly which messages will work with all people at risk of abusing drugs, Huskey said. In fact, the results suggest that there may be different types of drug users who will respond to different types of messages.
The important point is that “we found neural evidence that people at risk for drug use are processing these anti-drug messages differently than other viewers,” he said.
“Some of the follow-up work we’re doing is to better understand the various dimensions that put people at risk of using drugs so we can tailor messages in a more targeted way. This is just the first step in figuring out how to design messages that will be effective in discouraging drug use in these high-risk people.”
The Latest on: Brain scans
- Brain cancer survivor marks Thanksgiving milestoneon November 23, 2020 at 11:01 pm
Thanksgiving in 2015, Mike Schuster’s life changed in an instant. Schuster, then 50, blacked out when he suffered a seizure while working at his desk at a roofing company in Newcastle. The next thing ...
- Even 'Safe' Levels of Air Pollution Tied to Brain Shrinkageon November 23, 2020 at 1:26 pm
Even "safe" levels of air pollution may contribute to brain shrinkage and subsequent development of Alzheimer's disease.
- Neuroscientists find that isolation provokes brain activity similar to that seen during hunger cravingson November 23, 2020 at 12:41 pm
Since the coronavirus pandemic began in the spring, many people have only seen their close friends and loved ones during video calls, if at all. A new study from MIT finds that the longings we feel ...
- Brain Lesions Larger, More Numerous With Bicuspid TAVRon November 23, 2020 at 11:00 am
Results of diffusion-weighted magnetic resonance imaging (MRI) several days after TAVR were compared ... to show whether TAVR is suitable for BAV patients when considering brain injury complications.
- Imaging method reveals a “symphony of cellular activities”on November 23, 2020 at 8:41 am
MIT researchers have developed a way to simultaneously image up to five different molecules within a cell, by targeting glowing reporters to distinct locations inside the cell. This approach could ...
- Doctors TWICE failed to sanction emergency scan for young student who died from bleed on brain as HSE says sorryon November 22, 2020 at 11:36 pm
A SHOCKING litany of failures can today be laid bare into the care of a young university student who died from a bleed on the brain after doctors did not sanction an emergency out-of-hours scan. Lisa ...
- Diabetes, hypertension may increase risk of COVID-19 brain complicationson November 21, 2020 at 6:29 am
Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a new study. The researchers said these potentially life-threatening ...
- Brain-boosting supplements may have high doses of unapproved Rx medicationson November 20, 2020 at 8:51 pm
Combining different drugs can make them more risky, and some of the combinations in these products have never been studied for safety or efficacy, study co-author says.
- Early details of brain damage in COVID-19 patientson November 19, 2020 at 12:04 pm
Looking at six patients using a specialized magnetic resonance technique, researchers found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain ...
- AI that can diagnose tinnitus from brain scans may improve treatmenton November 18, 2020 at 9:36 pm
An artificial intelligence that can diagnose tinnitus based on the results of brain imaging, rather than subjective tests, may help improve treatments for the condition. Mehrnaz Shoushtarian at the ...
via Google News and Bing News